Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TETRAFERRIC TRICITRATE DECAHYDRATE for Hyperphosphataemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 682 adverse event reports in the FDA FAERS database where TETRAFERRIC TRICITRATE DECAHYDRATE was used for Hyperphosphataemia.

Most Reported Side Effects for TETRAFERRIC TRICITRATE DECAHYDRATE

Side Effect Reports % Deaths Hosp.
Diarrhoea 252 15.2% 0 14
Serum ferritin increased 227 13.7% 0 5
Transferrin saturation increased 169 10.2% 0 2
Faeces discoloured 111 6.7% 0 5
Death 72 4.3% 70 14
Constipation 64 3.9% 0 9
Drug ineffective 54 3.3% 0 4
Pruritus 47 2.8% 0 3
Nausea 44 2.7% 1 4
Vomiting 43 2.6% 1 5
Gastrointestinal haemorrhage 42 2.5% 3 15
Haemoglobin increased 40 2.4% 0 3
Prescribed overdose 38 2.3% 0 0
Abdominal discomfort 34 2.0% 1 3
Blood phosphorus increased 33 2.0% 0 1

Other Indications for TETRAFERRIC TRICITRATE DECAHYDRATE

Product used for unknown indication (722) Blood phosphorus increased (178) Iron deficiency anaemia (28) Chronic kidney disease (10) Dialysis (10) End stage renal disease (10) Anaemia (5)

Other Drugs Used for Hyperphosphataemia

TENAPANOR (598) SEVELAMER (533) LANTHANUM (528) FERRIC OXYHYDROXIDE (492) FERRIC ANHYDROUS (275) SUCROFERRIC OXYHYDROXIDE (124) CALCIUM (76) 405 (24) RENVELA (22) FOSRENOL (16)

Related Pages

TETRAFERRIC TRICITRATE DECAHYDRATE Full Profile All Hyperphosphataemia Drugs TETRAFERRIC TRICITRATE DECAHYDRATE Demographics TETRAFERRIC TRICITRATE DECAHYDRATE Timeline